Home > Boards > US Listed > Biotechs > iBio, Inc. (IBIO)

I don't see the problem, legal or otherwise.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
mastaflash Member Profile
 
Followed By 162
Posts 33,437
Boards Moderated 1
Alias Born 01/26/05
160x600 placeholder
iBio says successful in preclinical studies for subunit COVID-19 vaccine candidate Seeking Alpha - 7/16/2021 7:24:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/16/2021 6:04:34 AM
iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate GlobeNewswire Inc. - 7/15/2021 5:10:00 PM
iBio establishes oncology drug discovery pipeline with three new antibody programs Seeking Alpha - 7/8/2021 4:23:04 PM
iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs GlobeNewswire Inc. - 7/8/2021 4:15:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/9/2021 5:20:28 PM
iBio adds veteran biopharmaceutical executive to board of directors Seeking Alpha - 6/9/2021 4:44:08 PM
iBio Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive, Eef Schimmelpennink GlobeNewswire Inc. - 6/9/2021 4:30:00 PM
iBio to Present at the UBS Global Healthcare Virtual Conference GlobeNewswire Inc. - 5/19/2021 4:30:00 PM
iBio Q1 net loss widens as expenses soar year-over-year; shares fall 6% Seeking Alpha - 5/17/2021 10:08:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/17/2021 7:16:10 AM
iBio revenue in-line Seeking Alpha - 5/17/2021 7:04:02 AM
iBio Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 5/17/2021 7:00:00 AM
iBio to Report Fiscal 2021 Third Quarter Financial Results and Provide Corporate Update on Monday, May 17, 2021 GlobeNewswire Inc. - 5/10/2021 8:15:00 AM
ChemoCentryx downgraded on narrow Adcom backing, Tilray jumps on double upgrade; in today’s analyst action Seeking Alpha - 5/7/2021 8:57:30 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2021 4:46:04 PM
iBio shares surge on COVID-19 study update Seeking Alpha - 5/6/2021 4:42:34 PM
iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program GlobeNewswire Inc. - 5/6/2021 4:15:00 PM
Regional Health Properties, Chiasma leads healthcare gainers; Cocrystal Pharma, Esperion Therapeutics among major losers Seeking Alpha - 5/5/2021 11:00:10 AM
ATVI, TEVA, AYX and LYFT among notable premarket gainers Seeking Alpha - 5/5/2021 8:24:13 AM
iBio shares surge after resolving Fraunhofer USA lawsuit Seeking Alpha - 5/4/2021 5:28:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/4/2021 5:16:26 PM
iBio and Fraunhofer USA Conclude Litigation and Enter License Agreement GlobeNewswire Inc. - 5/4/2021 5:00:00 PM
iBio to Participate in the 33rd Annual Roth Conference GlobeNewswire Inc. - 3/9/2021 4:30:00 PM
Despite narrower fiscal Q2 2021 loss, iBio expenses grow; shares fall after hours Seeking Alpha - 2/16/2021 4:54:50 PM
mastaflash   Wednesday, 10/29/14 01:29:00 PM
Re: thecrusher2011 post# 9243
Post # of 26219 
I don't see the problem, legal or otherwise. Their process has a wide application...including Ebola...which is all they said. Investors asked " could your process be used to make Ebola antigens?" The answer is "yes it could, but is not currently." The rest is speculation, which is what we are doing here.


Some sheep are smarter than others.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences